BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 25609598)

  • 21. Evidence for enhanced androgen action in the prefrontal cortex of people with bipolar disorder but not schizophrenia or major depressive disorder.
    Owens SJ; Purves-Tyson TD; Webster MJ; Shannon Weickert C
    Psychiatry Res; 2019 Oct; 280():112503. PubMed ID: 31446215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional connectomics of affective and psychotic pathology.
    Baker JT; Dillon DG; Patrick LM; Roffman JL; Brady RO; Pizzagalli DA; Öngür D; Holmes AJ
    Proc Natl Acad Sci U S A; 2019 Apr; 116(18):9050-9059. PubMed ID: 30988201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic dysfunctions in the kynurenine pathway, noradrenergic and purine metabolism in schizophrenia and bipolar disorders.
    Steen NE; Dieset I; Hope S; Vedal TSJ; Smeland OB; Matson W; Kaddurah-Daouk R; Agartz I; Melle I; Djurovic S; Jönsson EG; Bogdanov M; Andreassen OA
    Psychol Med; 2020 Mar; 50(4):595-606. PubMed ID: 30867076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain bioenergetics and redox state measured by
    Chouinard VA; Kim SY; Valeri L; Yuksel C; Ryan KP; Chouinard G; Cohen BM; Du F; Öngür D
    Schizophr Res; 2017 Sep; 187():11-16. PubMed ID: 28258794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fatty acid composition of the postmortem corpus callosum of patients with schizophrenia, bipolar disorder, or major depressive disorder.
    Hamazaki K; Maekawa M; Toyota T; Dean B; Hamazaki T; Yoshikawa T
    Eur Psychiatry; 2017 Jan; 39():51-56. PubMed ID: 27821355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of HDAC2 but Not HDAC1 Transcript Is Reduced in Dorsolateral Prefrontal Cortex of Patients with Schizophrenia.
    Schroeder FA; Gilbert TM; Feng N; Taillon BD; Volkow ND; Innis RB; Hooker JM; Lipska BK
    ACS Chem Neurosci; 2017 Mar; 8(3):662-668. PubMed ID: 27959513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Search for peripheral biomarkers in patients affected by acutely psychotic bipolar disorder: a proteomic approach.
    Giusti L; Mantua V; Da Valle Y; Ciregia F; Ventroni T; Orsolini G; Donadio E; Giannaccini G; Mauri M; Cassano GB; Lucacchini A
    Mol Biosyst; 2014 Jun; 10(6):1246-54. PubMed ID: 24554194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorder.
    Lanz TA; Reinhart V; Sheehan MJ; Rizzo SJS; Bove SE; James LC; Volfson D; Lewis DA; Kleiman RJ
    Transl Psychiatry; 2019 May; 9(1):151. PubMed ID: 31123247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of ZNF804A in human brain and alterations in schizophrenia, bipolar disorder, and major depressive disorder: a novel transcript fetally regulated by the psychosis risk variant rs1344706.
    Tao R; Cousijn H; Jaffe AE; Burnet PW; Edwards F; Eastwood SL; Shin JH; Lane TA; Walker MA; Maher BJ; Weinberger DR; Harrison PJ; Hyde TM; Kleinman JE
    JAMA Psychiatry; 2014 Oct; 71(10):1112-20. PubMed ID: 25162540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the validity and utility of a transdiagnostic psychosis dimension encompassing schizophrenia and bipolar disorder.
    Reininghaus U; Böhnke JR; Hosang G; Farmer A; Burns T; McGuffin P; Bentall RP
    Br J Psychiatry; 2016 Aug; 209(2):107-13. PubMed ID: 26989099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder.
    McCullumsmith RE; Meador-Woodruff JH
    Neuropsychopharmacology; 2002 Mar; 26(3):368-75. PubMed ID: 11850151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fatty acid composition of the postmortem prefrontal cortex of patients with schizophrenia, bipolar disorder, and major depressive disorder.
    Hamazaki K; Maekawa M; Toyota T; Dean B; Hamazaki T; Yoshikawa T
    Psychiatry Res; 2015 Jun; 227(2-3):353-9. PubMed ID: 25858798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Similarities in Cortical Transcriptome Alterations Between Schizophrenia and Bipolar Disorder Are Related to the Presence of Psychosis.
    Enwright JF; Lewis DA
    Schizophr Bull; 2021 Aug; 47(5):1442-1451. PubMed ID: 33442739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease-associated changes.
    Beasley CL; Pennington K; Behan A; Wait R; Dunn MJ; Cotter D
    Proteomics; 2006 Jun; 6(11):3414-25. PubMed ID: 16637010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction and analysis of the protein-protein interaction networks for schizophrenia, bipolar disorder, and major depression.
    Lee SA; Tsao TT; Yang KC; Lin H; Kuo YL; Hsu CH; Lee WK; Huang KC; Kao CY
    BMC Bioinformatics; 2011; 12 Suppl 13(Suppl 13):S20. PubMed ID: 22373040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response suppression deficits in treatment-naïve first-episode patients with schizophrenia, psychotic bipolar disorder and psychotic major depression.
    Harris MS; Reilly JL; Thase ME; Keshavan MS; Sweeney JA
    Psychiatry Res; 2009 Dec; 170(2-3):150-6. PubMed ID: 19906441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional magnetic resonance spectroscopy in patients with schizophrenia and bipolar affective disorder: Glutamate dynamics in the anterior cingulate cortex during a working memory task.
    Jelen LA; King S; Horne CM; Lythgoe DJ; Young AH; Stone JM
    Eur Neuropsychopharmacol; 2019 Dec; 29(2):222-234. PubMed ID: 30558824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased expression of mineralocorticoid receptor mRNA in the prefrontal cortex in schizophrenia and bipolar disorder.
    Xing GQ; Russell S; Webster MJ; Post RM
    Int J Neuropsychopharmacol; 2004 Jun; 7(2):143-53. PubMed ID: 14741058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains.
    Torrey EF; Barci BM; Webster MJ; Bartko JJ; Meador-Woodruff JH; Knable MB
    Biol Psychiatry; 2005 Feb; 57(3):252-60. PubMed ID: 15691526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered histamine H3 receptor radioligand binding in post-mortem brain samples from subjects with psychiatric diseases.
    Jin CY; Anichtchik O; Panula P
    Br J Pharmacol; 2009 May; 157(1):118-29. PubMed ID: 19413576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.